Molecular Mechanisms of Estrogen Carcinogenesis

In western society, the causes of several cancers--including breast, endometrium, ovary, liver, and prostate--have been linked to inappropriate and/or prolonged exposure to synthetic or endogenous steroidal hormones. In this review, we discuss the mechanisms of estrogen carcinogenesis with a focus on estrogen metabolism to 16 alpha-hydroxy estrone and 2- and 4-hydroxy catechol estrogens and the potential effects of these metabolites in vitro and in vivo on hamster liver and kidney and rat liver carcinogenesis models. The examples demonstrate that the parent compounds and their metabolites cause both nongenotoxic cell proliferative effects as well as direct and indirect genotoxic effects, which illustrates the complex nature of estrogen carcinogenesis. These effects, in combination with the metabolic state of the tissue and the timing of its exposure, may determine the cell type (organ) of tumor development and the severity of disease.

[1]  J. Liehr,et al.  Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. , 1995, Carcinogenesis.

[2]  J. Liehr,et al.  Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. , 1995, Carcinogenesis.

[3]  S. Ethier Growth factor synthesis and human breast cancer progression. , 1995, Journal of the National Cancer Institute.

[4]  C M King,et al.  Tamoxifen and the induction of cancer. , 1995, Carcinogenesis.

[5]  L. Gray,et al.  Persistent DDT metabolite p,p'–DDE is a potent androgen receptor antagonist , 1995, Nature.

[6]  G. Clark,et al.  Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals. , 1995, Carcinogenesis.

[7]  D. Roy,et al.  Activation of phosphorylation of plasma membrane insulin-like growth factor-I receptors in the kidney of Syrian hamsters by diethylstilbestrol. , 1995, Carcinogenesis.

[8]  R. Guzman,et al.  Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Hirohashi,et al.  8-hydroxydeoxyguanosine levels in DNA of human breast cancer are not significantly different from those of non-cancerous breast tissues by the HPLC-ECD method. , 1995, Cancer letters.

[10]  E. Ohtsuka,et al.  8-Hydroxyguanine (7,8-dihydro-8-oxoguanine) in hot spots of the c-Ha-ras gene: effects of sequence contexts on mutation spectra. , 1995, Carcinogenesis.

[11]  S. Safe,et al.  Environmental and dietary estrogens and human health: is there a problem? , 1995, Environmental health perspectives.

[12]  J. Zweier,et al.  ESR evidence for the generation of reactive oxygen species from the copper-mediated oxidation of the benzene metabolite, hydroquinone: role in DNA damage. , 1995, Chemico-biological interactions.

[13]  J. Liehr,et al.  Lipid hydroperoxide-induced endogenous DNA adducts in hamsters: possible mechanism of lipid hydroperoxide-mediated carcinogenesis. , 1995, Archives of biochemistry and biophysics.

[14]  D. Roy,et al.  Catalysis of the oxidation and reduction reactions of steroid and stilbene estrogens by nuclear enzymes. , 1994, Archives of biochemistry and biophysics.

[15]  J. Li,et al.  Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogens. , 1994, Mutation research.

[16]  J. Liehr,et al.  8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. , 1994, Cancer research.

[17]  G. Lucier,et al.  Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol. , 1994, Carcinogenesis.

[18]  D. Miller,et al.  Long-term responses of women to indole-3-carbinol or a high fiber diet. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  L. Nutter,et al.  Cellular biochemical determinants modulating the metabolism of estrone 3,4-quinone. , 1994, Chemical research in toxicology.

[20]  H. Bradlow,et al.  Alterations in estradiol metabolism in MCF-7 cells induced by treatment with indole-3-carbinol and related compounds , 1994, Steroids.

[21]  E. Cavalieri Minisymposium on Endogenous Carcinogens: The Catechol Estrogen Pathway. An Introduction , 1994 .

[22]  J. Yager,et al.  DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. , 1994, Carcinogenesis.

[23]  E. Jabs,et al.  Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. , 1994, The Journal of biological chemistry.

[24]  J. Liehr,et al.  DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. , 1994, Carcinogenesis.

[25]  M. Osborne,et al.  Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen, or β-naphthaflavone: A comparison of stable isotope dilution gas chromatography-mass spectrometry and radiometric methods , 1994, Steroids.

[26]  B. Macmahon Pesticide residues and breast cancer? , 1994, Journal of the National Cancer Institute.

[27]  J. Liehr,et al.  Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. , 1994, Toxicology and applied pharmacology.

[28]  L. Nutter,et al.  An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage. , 1994, Chemical research in toxicology.

[29]  D. Nebert,et al.  Elevated estrogen 16 alpha-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk? , 1993, Journal of the National Cancer Institute.

[30]  R. Korah,et al.  Mutagenic and recombinagenic effects of diethylstilbestrol quinone. , 1993, Mutation research.

[31]  L. Sheffield,et al.  Estrogen enhances epidermal growth factor‐induced DNA synthesis in mammary epithelial cells , 1993, Journal of cellular physiology.

[32]  M. Trush,et al.  DNA damage resulting from the oxidation of hydroquinone by copper: role for a Cu(II)/Cu(I) redox cycle and reactive oxygen generation. , 1993, Carcinogenesis.

[33]  M. Gould Cellular and molecular aspects of the multistage progression of mammary carcinogenesis in humans and rats. , 1993, Seminars in cancer biology.

[34]  N. Polissar,et al.  The etiology of breast cancer characteristic alterations in hydroxyl radical‐induced dna base lesions during oncogenesis with potential for evaluating incidence risk , 1993, Cancer.

[35]  J. Liehr,et al.  Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis. , 1993, Molecular pharmacology.

[36]  B. E. Walker,et al.  Pituitary tumors in mice exposed prenatally to diethylstilbestrol. , 1993, Cancer research.

[37]  Y. Osawa,et al.  Multiple functions of aromatase and the active site structure; aromatase is the placental estrogen 2-hydroxylase , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[38]  M. Osborne,et al.  Genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. , 1993, Recent progress in hormone research.

[39]  C. Martucci,et al.  P450 enzymes of estrogen metabolism. , 1993, Pharmacology & therapeutics.

[40]  M. Trush,et al.  Oxidation of hydroquinone by copper: chemical mechanism and biological effects. , 1993, Archives of biochemistry and biophysics.

[41]  R. Davies,et al.  Ethinyl estradiol-induced cell proliferation in rat liver. Involvement of specific populations of hepatocytes. , 1992, Carcinogenesis.

[42]  J. Doroshow,et al.  Copper-dependent site-specific mutagenesis by benzoyl peroxide in the supF gene of the mutation reporter plasmid pS189. , 1992, Carcinogenesis.

[43]  J. D. Frank,et al.  Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate. , 1992, Toxicology and applied pharmacology.

[44]  K. El-Bayoumy Environmental carcinogens that may be involved in human breast cancer etiology. , 1992, Chemical research in toxicology.

[45]  H. Strobel,et al.  Catalysis of the oxidation of steroid and stilbene estrogens to estrogen quinone metabolites by the beta-naphthoflavone-inducible cytochrome P450 IA family. , 1992, Archives of biochemistry and biophysics.

[46]  R. Mizumoto,et al.  32P‐Postlabeling Analysis of DNA Adducts in Rats during Estrogen‐induced Hepatocarcinogenesis and Effect of Tamoxifen on DNA Adduct Level , 1992, Japanese journal of cancer research : Gann.

[47]  M. Metzler,et al.  Interactions of Carcinogenic Estrogens with Microtubular Proteins , 1992 .

[48]  J. Fishman,et al.  Differential Interactions of Estradiol Metabolites with the Estrogen Receptor: Genomic Consequences and Tumorigenesis , 1992 .

[49]  SaraAntonia Li,et al.  Synthetic Estrogens and Liver Cancer: Risk Analysis of Animal and Human Data , 1992 .

[50]  H. Bern Diethylstilbestrol (DES) Syndrome: Present Status of Animal and Human Studies , 1992 .

[51]  A. Wang,et al.  Covalent modification of guanine bases in double-stranded DNA. The 1.2-A Z-DNA structure of d(CGCGCG) in the presence of CuCl2. , 1992, The Journal of biological chemistry.

[52]  J. Yager,et al.  Sex Hormones and Tumor Promotion in Liver , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[53]  G. Quigley,et al.  Base-specific binding of copper(II) to Z-DNA. The 1.3-A single crystal structure of d(m5CGUAm5CG) in the presence of CuCl2. , 1991, The Journal of biological chemistry.

[54]  D. Roy,et al.  Xanthine oxidase-catalyzed reduction of estrogen quinones to semiquinones and hydroquinones. , 1991, Biochemical pharmacology.

[55]  L. Nutter,et al.  Characterization of DNA damage induced by 3,4-estrone-o-quinone in human cells. , 1991, The Journal of biological chemistry.

[56]  G. Michalopoulos,et al.  Long-term treatment with hepatic tumor promoters inhibits mitogenic responses of hepatocytes to acidic fibroblast growth factor and hepatocyte growth factor. , 1991, Cancer letters.

[57]  J. Liehr,et al.  Elevated 8-hydroxydeoxyguanosine levels in DNA of diethylstilbestrol-treated Syrian hamsters: covalent DNA damage by free radicals generated by redox cycling of diethylstilbestrol. , 1991, Cancer research.

[58]  T. Nambara,et al.  Structure of the adduct of 16α-hydroxyestrone with a primary amine: evidence for the heyns rearrangement of steroidal D-ring α-hydroxyimines , 1991, Steroids.

[59]  T. Shimada,et al.  Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. , 1991, Chemical research in toxicology.

[60]  W. Schulz,et al.  Formation of 8-hydroxy(deoxy)guanosine and generation of strand breaks at guanine residues in DNA by singlet oxygen. , 1991, Biochemistry.

[61]  J. Liehr,et al.  Transplacental genotoxicity of diethylstilbestrol. , 1991, Carcinogenesis.

[62]  H. Strobel,et al.  Cytochrome b5-mediated redox cycling of estrogen. , 1991, Archives of biochemistry and biophysics.

[63]  J. Zweier,et al.  Role of the benzoyloxyl radical in DNA damage mediated by benzoyl peroxide. , 1991, Chemical research in toxicology.

[64]  J. McLachlan,et al.  Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. , 1990, Cancer research.

[65]  M. Metzler,et al.  Covalent binding of reactive estrogen metabolites to microtubular protein as a possible mechanism of aneuploidy induction and neoplastic cell transformation. , 1990, Environmental health perspectives.

[66]  J. Yager,et al.  Regulation of rat hepatocyte epidermal growth factor receptor by the liver tumor promoter ethinyl estradiol. , 1990, Carcinogenesis.

[67]  K. Ishak,et al.  Estrogen induction of hepatocellular carcinomas in Armenian hamsters , 1990, Hepatology.

[68]  J. Barrett,et al.  Aneuploidy induction in human fibroblasts: comparison with results in Syrian hamster fibroblasts. , 1990, Mutation research.

[69]  S. Shapiro,et al.  Oral contraceptive use and liver cancer. , 1989, American journal of epidemiology.

[70]  J. Liehr,et al.  Mechanism of genotoxicity of diethylstilbestrol in vivo. , 1989, The Journal of biological chemistry.

[71]  J. Yager,et al.  Effects of the liver tumor promoter ethinyl estradiol on epidermal growth factor-induced DNA synthesis and epidermal growth factor receptor levels in cultured rat hepatocytes. , 1989, Cancer research.

[72]  J. Wittliff,et al.  Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers. , 1989, Journal of steroid biochemistry.

[73]  V. Mazzaferro,et al.  The effect of estrogen and tamoxifen on hepatocyte proliferation in Vivo and in Vitro , 1989, Hepatology.

[74]  S. Goldfarb,et al.  Specific estrogen-induced cell proliferation of cultured Syrian hamster renal proximal tubular cells in serum-free chemically defined media. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[75]  J. Li,et al.  Morphological and immunohistochemical studies of the estrogen-induced Syrian hamster renal tumor: probable cell of origin. , 1989, Cancer research.

[76]  J. Weisz,et al.  Monooxygenase mediating catecholestrogen formation by rat anterior pituitary is an estrogen-4-hydroxylase. , 1989, Endocrinology.

[77]  G. Talukder,et al.  Effects of copper on mammalian cell components. , 1989, Chemico-biological interactions.

[78]  I. Leav,et al.  Androgen‐supported estrogen‐enhanced epithelial proliferation in the prostates of intact noble rats , 1989, The Prostate.

[79]  R. Jirtle,et al.  Phenobarbital reduces EGF receptors and the ability of physiological concentrations of calcium to suppress hepatocyte proliferation. , 1988, Carcinogenesis.

[80]  J. Liehr,et al.  Histochemical analysis of the development of estradiol-induced kidney tumors in male Syrian hamsters. , 1988, Cancer research.

[81]  M. Metzler,et al.  Site-specific covalent binding of stilbene-type and steroidal estrogens to tubulin following metabolic activation in vitro. , 1987, Carcinogenesis.

[82]  J. Yager,et al.  Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats. , 1986, Carcinogenesis.

[83]  J. Barrett,et al.  Alteration in diethylstilbestrol-induced mutagenicity and cell transformation by exogenous metabolic activation. , 1986, Carcinogenesis.

[84]  H. Bradlow,et al.  16α‐Hydroxylation of Estradiol: A Possible Risk Marker for Breast Cancer , 1986 .

[85]  R. Schulte‐Hermann,et al.  Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. , 1986, Cancer research.

[86]  H. Adlercreutz,et al.  Urinary estrogen profile determination in young Finnish vegetarian and omnivorous women. , 1986, Journal of Steroid Biochemistry.

[87]  M. Metzler,et al.  Co-oxidation of diethylstilbestrol and structural analogs by prostaglandin synthase. , 1986, Carcinogenesis.

[88]  J. Liehr,et al.  Carcinogenicity of catechol estrogens in Syrian hamsters. , 1986, Journal of steroid biochemistry.

[89]  H. Bradlow,et al.  Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[90]  K. Yokoro,et al.  Inhibition by 3-amino-1H-1,2,4-triazole of hepatic tumorigenesis induced by diethylstilbestrol alone or combined with N-nitrosobutylurea in WF rats. , 1985, Journal of the National Cancer Institute.

[91]  J. Li,et al.  Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in the hamster kidney. , 1985, Cancer research.

[92]  J. Yager,et al.  Enhancement of hepatocarcinogenesis in female rats by ethinyl estradiol and mestranol but not estradiol. , 1984, Cancer research.

[93]  J. Li,et al.  High incidence of hepatocellular carcinomas after synthetic estrogen administration in Syrian golden hamsters fed alpha-naphthoflavone: a new tumor model. , 1984, Journal of the National Cancer Institute.

[94]  H. Bradlow,et al.  Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. , 1984, The Journal of biological chemistry.

[95]  K. Yokoro,et al.  Inhibitory effect of antiestrogen on hepatic tumorigenesis in WF rats treated with diethylstilbestrol alone or in combination with N-nitrosobutylurea. , 1984, Journal of the National Cancer Institute.

[96]  J. Henkin,et al.  Diethylstilbestrol (DES) quinone: a reactive intermediate in DES metabolism. , 1983, Biochemical pharmacology.

[97]  J. Li,et al.  Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. , 1983, Cancer research.

[98]  J. Barrett,et al.  Aneuploidy induction and cell transformation by diethylstilbestrol: a possible chromosomal mechanism in carcinogenesis. , 1983, Cancer research.

[99]  F. Naftolin,et al.  Kinetics of catechol estrogen-estrogen receptor dissociation: A possible factor underlying differences in catechol estrogen biological activity , 1983, Steroids.

[100]  H. Barbason,et al.  Promotion mechanism of phenobarbital and partial hepatectomy in DENA hepatocarcinogenesis cell kinetics effect. , 1983, British Journal of Cancer.

[101]  R. Bucala,et al.  Formation of covalent adducts between cortisol and 16 alpha-hydroxyestrone and protein: possible role in the pathogenesis of cortisol toxicity and systemic lupus erythematosus. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[102]  J. Yager,et al.  Lack of hepatogenotoxicity of oral contraceptive steroids. , 1982, Carcinogenesis.

[103]  J. Barrett,et al.  Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci. , 1981, Science.

[104]  R. A. Huseby Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse. , 1980, Cancer research.

[105]  L. Jones,et al.  Transplantability and sex steroid hormone responsiveness of cervicovaginal tumors derived from female BALB/cCrgl mice neonatally treated with ovarian steroids. , 1979, Cancer research.

[106]  D. Casciano,et al.  Metabolism of 17α‐ethynylestradiol by intact liver parenchymal cells isolated from mouse and rat , 1977 .

[107]  D. Sirbasku,et al.  Control of cell growth. IV. Growth properties of a new cell line established from an estrogen-dependent kidney tumor of the Syrian hamster. , 1976, Endocrinology.

[108]  H. Kirkman Estrogen-induced tumors of the kidney. IV. Incidence in female Syrian hamsters. , 1959, National Cancer Institute monograph.

[109]  H. Kirkman,et al.  Estrogen-induced tumors of the kidney. V. Histology and histogenesis in the Syrian hamster. , 1959, National Cancer Institute monograph.